Cogent Biosciences (COGT) Preferred Shares (2020)
Cogent Biosciences has reported Preferred Shares over the past 1 years, most recently at $110.9 million for Q4 2020.
- Quarterly results put Preferred Shares at $110.9 million for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $110.9 million (changed N/A YoY), and the annual figure for FY2020 was $110.9 million, changed.
- Preferred Shares for Q4 2020 was $110.9 million at Cogent Biosciences.
- Over the last five years, Preferred Shares for COGT hit a ceiling of $110.9 million in Q4 2020 and a floor of $110.9 million in Q4 2020.